Systematic Assessment of Risk of Fever in Solid Tumor Patients Treated With PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis

Purpose: Drug-induced fever is frequently reported in cancer patients treated with anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1), and stoppage of the offending agent is the management of choice. However, given the complex management of cancer patients, this needs to be c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongmei, Xu, Dongmei, Wang, Wentao, Sun, Fengchao, Zhang, Shuisheng, Yang, Xiaowei, Tian, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658543/
https://www.ncbi.nlm.nih.gov/pubmed/33194659
http://dx.doi.org/10.3389/fonc.2020.570080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658543/
https://www.ncbi.nlm.nih.gov/pubmed/33194659
http://dx.doi.org/10.3389/fonc.2020.570080

Ejemplares similares